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Brucellaa b s t r a c t
BtpA/Btp1/TcpB is a virulence factor produced by Brucella species that possesses a Toll interleukin-1
receptor (TIR) domain. Once delivered into the host cell, BtpA interacts with MyD88 to interfere with
TLR signalling and modulates microtubule dynamics. Here the crystal structure of the BtpA TIR
domain at 3.15 Å is presented. The structure shows a dimeric arrangement of a canonical TIR
domain, similar to the Paracoccus denitriﬁcans Tir protein but secured by a unique long N-terminal
a-tail that packs against the TIR:TIR dimer. Structure-based mutations andmulti-angle light scatter-
ing experiments characterized the BtpA dimer conformation in solution. The structure of BtpA will
help with studies to understand the mechanisms involved in its interactions with MyD88 and with
microtubules.
Structured digital abstract:
BtpA and BtpA bind by x-ray crystallography (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Toll/like receptors (TLRs) are transmembrane proteins that
sense pathogens and initiate innate immune signalling cascades.
Signalling through TLRs involves homo and heterotypic interac-
tions of their Toll/interleukin 1 receptor (TIR) domains with cyto-
solic TIR domain containing adaptors such as MyD88 and TIRAP,
that leads to proinﬂammatory responses [1]. Structural studies
have revealed that TIR domains consist of a parallel ﬁve-stranded
b sheet (bA–bE) surrounded by a helices (aA–aE) connected by
more variable loops, probably illustrating the versatile nature of
these domains [2–10].
Because of their central role in host defence, TLR signalling
pathways are targets for bacterial pathogens to modulate host in-
nate immune responses during the course of infection. One re-
cently discovered strategy involves bacterial TIR domain-
containing proteins of pathogenic bacteria that interfere directly
with TLR signalling [11]. The bacterial TIR proteins TcpC (Esche-
richia coli), TcpB/Btp1 (Brucella), TlpA (Salmonella enterica) and
YpdTir (Yersinia pestis) have been studied in detail [12–15].The zoonotic pathogen Brucella is the causative agent of brucel-
losis (or Malta fever) and relies on its VirB type IV secretion system
(T4SS) to survive and multiply within host-cells [16–18]. Brucella
species produce a TIR protein named BtpA (previously called
Btp1 or TcpB [12,13]) translocated by the Brucella T4SS into host
cells during infection [13,14,19]. Here, BtpA interferes with TLR2
and TLR4 signalling, resulting in the reduction of dendritic cell
(DC) maturation, inhibition of pro-inﬂammatory cytokine secre-
tion [13] and impaired NF-jB activation in macrophages [14], pos-
sibly by inducing the ubiquitination and degradation of TIRAP [20].
In vivo pull down assays showed that BtpA interacts with TIRAP
but not with MyD88 [20]. However yeast two-hybrid assays estab-
lished that BtpA interacts with MyD88 [21]. Moreover, in vivo
split-GFP experiments showed that the interaction with BtpA re-
quires the MyD88 death domain, rather than the TIR domain
[21]. The BtpA TIR domain, however, has been shown to be re-
quired for association with microtubules, and to prevent microtu-
bule depolymerisation [22].
To better understand the structural basis of the mode of action
of BtpA we have solved the crystal structure of its TIR domain at
3.15 Å. The structure shows a canonical TIR fold and a quaternary
arrangement resembling that of the Paracoccus denitriﬁcans TIR do-
main (PdTIR) [5]. Our structural and biochemical characterisation
Table 1
Data collection and reﬁnement statistics.
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important implications for its mode of action in the host cell.BtpA TIR
Space group P22121
Wavelength (Å) 0.97627
Cell parameters, a, b, c (Å) 68.14, 73.93, 137.64
Resolution range (Å) 48.4–3.15 (3.26–3.15)
Rmerge 0.169 (0.66)
Rp.i.m. 0.112 (0.47)
Number of observed reﬂections 43030 (6288)
Number of unique reﬂections 12251 (1768)
Mean (I/s(I)) 5.3 (1.5)
Completeness (%) 98.1 (99.2)
Multiplicity 3.5 (3.6)
Reﬁnement statistics
Resolution range for reﬁnement (Å) 48.4–3.15
Number of unique reﬂections in reﬁnement 22751
Working set 21668
Test set 1083
Completeness (%) 97.9
Monomers/ASU 4
No. protein atoms 4669
Rwork/Rfree 0.222/0.278
Rmsd bonds (Å) 0.009
Rmsd angles (o) 1.0
Ramachandran plot
Most favoured (%) 94.2
Allowed (%) and generously allowed (%) 5.8
Outliers (%) 0
aValues in parentheses refer to the indicated resolution shell.2. Materials and methods
2.1. Cloning, expression, and puriﬁcation of BtpA
A 828 bp PCR fragment encoding BtpA from Brucella melitensis
16M genomic DNA was cloned into the pET151D topo vector
(Invitrogen). Point mutations were introduced using the Quick-
Change mutagenesis kit (Stratagene) following manufacturer’s
protocol. E. coli BL21(DE3) cells carrying the resulting plasmids
were grown in LB media containing ampicillin at 37 C until an
OD600 of 0.7 when protein expression was induced by the addition
of 1 mM isopropyl-b-D-thiogalactopyranoside overnight at 20 C.
Harvested cells were resuspended in lysis buffer (40 mM Tris pH
8, 300 mM NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100) supple-
mented with Dnase-I, lysozyme, and protease inhibitor tablets
(Roche). After sonication the cell lysate was cleared by centrifuga-
tion (16000g for 20 min). The cell lysate was loaded onto a 5-ml
His-Trap column (GE Healthcare) pre-equilibrated with buffer A
(40 mM Tris pH 8, 250 mM NaCl, 5% (v/v) glycerol). The column
was washed successively with buffer A, 10% (v/v) buffer B (buffer
A with 500 mM imidazole), and 1 M NaCl. The protein was eluted
with a linear gradient from 10–100% of buffer B. The fractions con-
taining 6his-BtpA containing were pooled and frozen. Protein used
for crystallogenesis was incubated with TEV protease (1:40), 1 mM
DTT and 0.5 mM EDTA, dialysed against buffer A at 4 C overnight
and then loaded on a His-trap column. Pure BtpA eluted with 10%
(v/v) buffer B. BtpA and 6his-BtpA were concentrated to 10 mg/ml
and applied to size exclusion chromatography (Superdex 75; GE
Healthcare) in buffer A. Similar protocols were used for production
of BtpA variants except that the 6his-tag was not cleaved.
2.2. Multi angle laser light scattering
Size-exclusion chromatography combined with multi angle la-
ser light scattering (MALLS) and refractometry experiments were
performed with an analytical Superdex 75 column (GE Healthcare)
equilibrated with buffer A. On-line MALLS detection was per-
formed with a miniDAWN-TREOS detector (Wyatt Technology)
using a laser emitting at 690 nm and by refractive index measure-
ment using an Optilab T-rex system (Wyatt Technology). Weight
averaged molar masses (Mw) were calculated using the ASTRA
software (Wyatt Technology).
2.3. Crystallisation, structure determination, and reﬁnement
BtpA crystals were obtained using the vapor-diffusion methods
by mixing 1.0 ll of protein with 1.0 ll of reservoir solution con-
taining PEG 4000 23–30%, (v/v), 100 mM sodium citrate pH 5.4–
5.6 and 200 mM ammonium acetate. Crystals were ﬂash-frozen
in liquid nitrogen after addition of a cryoprotectant solution con-
sisting of reservoir solution with glycerol (10% v/v). X-ray diffrac-
tion data were collected from native crystals at the ID23EH1
beamline of the ESRF (Grenoble). Data were indexed and integrated
using XDS [23] and scaled with SCALA [24]. The structure of BtpA
was solved by molecular replacement using Phaser [25,26] with
the PdTIR structure as a template (PDB 3H16) [5]. Initial molecular
replacement was done to search for two copies in the asymmetric
unit. The visual inspection of the electron density map identiﬁed
that the asymmetric unit contained four TIR domains. The molec-
ular replacement was repeated to search for four copies and the
model was build using Coot [27] and reﬁned using Phenix [28].
Data collection and reﬁnement statistics are given in Table 1. Thecoordinates of the BtpA TIR domain structure have been deposited
in the PDB, entry code 4LZP.
3. Results
3.1. Structure of the BtpA Tir domain
The structure of BtpA was solved at 3.15 Å and reﬁned to ﬁnal
Rwork/Rfree values of 22%/27%. Even though crystallization drops
were set-up with full-length BtpA, the crystals only contained a
C-terminal portion of the protein due to N-terminal degradation.
The asymmetric unit (AU) of BtpA crystals contains four chains ar-
ranged as two dimers AB and CD. Chains A and C encompass resi-
dues 100 to 275 and chains B and D are composed of residues 143
to 275 with some loops missing. As dimers AB and CD are almost
identical, only chains A and B will be described in this section. Res-
idues 100 to 133 of chain A form a long helix hereafter named a-
tail, that packs against the TIR domains of chains A and B
(Fig. 1A), comprised between residues 143 to 275. The TIR domain
of BtpA contains the canonical secondary structures described for
TIR domains: ﬁve parallel b-strands (bA to bE) surrounded by ﬁve
a-helices (Fig. 1A). There was no interpretable electron density
for the loop between aC and bD (CD loop) and for the loop connect-
ing the a-tail to the TIR domain (Fig. 1A). The TIR domains of the
four chains are almost identical and are more similar to the struc-
ture of PdTIR than to other TIR domains (Fig. 1B and Fig. S1).
Although the structures of PdTIR and BtpA TIR domains are very
similar, their DE loops are very different. Instead of a loop in PdTIR,
BtpA shows a short hydrophobic helix (D0). Interestingly a similar
short helix is present in the Myd88 and TIRAP/MAL adaptor pro-
teins at this position although the remaining parts of the TIR do-
main of these proteins are different (Fig. 1B).
3.2. A conserved dimeric organization in BtpA and PdTIR
In the asymmetric unit, the four chains present two different
interfaces similar to those observed for PdTIR. The most signiﬁcant
Fig. 1. (A) Two different cartoon representations of the BtpA dimer between chain A and chain B. Chain A is coloured according to secondary structure: helices in blue, strands
in magenta and loops in pink. Chain B is coloured in grey with its surface represented in transparency. (B) Structure superimposition of the BtpA TIR domain (blue) with PdTir
(orange), MyD88 (red) and TIRAP/MAL (yellow).
3414 B. Kaplan-Türköz et al. / FEBS Letters 587 (2013) 3412–3416interface (I) is found in the dimers AB and CD. A second signiﬁcant
interface (II) involved chain B and chain C (Fig. 2). Additional inter-
faces were also identiﬁed in the crystal packing but rely probably
on non-speciﬁc interactions as described in other TIR structuresFig. 2. (A) Ribbon representation of the BtpA crystal asymmetric unit showing chain A (da
and orange inserts) and one of interface II (pink insert). The orange insert shows the surfa
formed by the two TIR monomers. The a-tail is shown in ribbon and coloured in orange
stick and coloured in slate (carbon), red (oxygen), blue (nitrogen) or yellow (sulphur).[2,5]. Dimers AB and CD are composed of two TIR domains and
one a-tail and are almost identical with an interface burying
1200 Å2. The interface I relies on extensive electrostatic interac-
tions between the DD loop of one chain and EE loop and aC andrk blue), B (cyan), C (green) and D (grey) with two close-up views of interface I (blue
ce charge representation (blue positive and red negative) of the hydrophobic groove
. The side chain making contacts with the TIR domains are represented in ball-and-
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with carbonyl of T259 (EE loop) of chain B. S260 (EE loop) hydroxyl
of the two chains formed H-bonds and S260 of chain A also inter-
acts with backbone nitrogen of chain B V239 (DD loop). Reciprocal
interaction occurs between the side chain of D242 and of S263 (EE
loop) and backbone nitrogen of V264 (aE) and main chain-main
chain hydrogen bonds between carbonyl of T259 (EE loop) and
nitrogen Y241 (aD). K238 (DD loop) of chain A forms a salt bridge
with E206 and E243 (aC and aD, respectively) of chain B and vice
versa, an interaction conserved in the PdTIR dimer (K260–E265). In
BtpA, the a-tail of chain A packs against both TIR domains of the AB
dimer and inserts into a hydrophobic groove formed by the two TIR
domains (Fig. 2). In addition to the numerous hydrophobic interac-
tions mediated by side chains from the a-tail residues, several
hydrogen bonds secure the position of the helix (Fig. 2). It is note-
worthy that in this conformation, the a-tail of only one subunit can
be accommodated into the groove since the dimer is symmetrical.
So although the TIR:TIR dimer is symmetric, this organisation sug-
gests an asymmetric position for the coiled–coiled domain of BtpA.
The interface II was found between chains B and C and involved
amino acids from aA, BB loop, aE and EE loop. The interface also
relies on electrostatic interaction, including salt bridges between
chain B K269 (aE) and chain C D176 (BB loop), and chain B D168
(aA) and chain C R167 (aA). H-bonds were present between chain
B and C residues; S263 (EE) with Q160 (aA), backbone oxygen of
A164 (aA) with side chain of R167 (aA), backbone oxygen of
R167 with side chain of Y144 (bA) and D168 with backbone nitro-
gen atoms of Y175 (BB) and D176 (BB). The interface II had an area
of 295 Å2.
3.3. Mutational and biochemical characterisation of the BtpA dimer
To conﬁrm that the dimer was mediated via interface I, we gen-
erated BtpA variants aiming to disrupt interface I (S260A, K238E,
K238A, K238AS20A) or interface II (R167E, D176R) (Fig. S1). The
proteins were puriﬁed and their oligomeric states were evaluated
by size exclusion chromatography coupled (SEC) to multi angle la-
ser light scattering (MALLS) (Table 2). The puriﬁed BtpA with the
His-tag has a molecular mass of 34.7 kDa. The elution volume of
the protein in SEC is 9.1 ml and the calculated mass is 68 kDa.
These values indicate that BtpA is a dimer in solution. For the vari-
ants K238E and K238A, the proteins were hardly expressed in
E. coli suggesting that these changes affected protein stability
and/or were toxic for E. coli. Soluble BtpA variant proteins could
be obtained for S260A, R167E, D176R and, to a lesser extent, for
K238AS260A (Table 2). SEC-MALLS experiments showed that the
molecular mass obtained for S260A was 56 kDa with an elutionTable 2
Biochemical characterisation of His-BtpA and His-BtpA protein variants.
BtpA Interface/structural
element
Yielda Elution volume
(ml)
MMb
(kDa)
WT +++ 9.1 68 (1%)
S260A I/EE loop ++ 10.1 56 (4%)
K238E I/DD loop 
K238A I/DD loop 
K238ES260A I/ + 10.1 ND
R167E II/aA +++ 9.1 67.7
(2%)
D176R II/bB +++ 9.1 81.4
(5%)
a Yields range from no soluble protein () to 2 mg of puriﬁed protein/litre of
E. coli cell culture (+++).
b MM: molecular mass obtained in multi angle laser light scattering experiments.
Values in parentheses indicate the corresponding error percentage estimated with
the ASTRA software.volume of 10.1 ml. A similar elution volume was obtained for the
K238AS260A protein but the molecular mass could not be esti-
mated (Table 2). In contrast, variants targeting interface II showed
similar elution volumes and molecular masses to wild type BtpA
(Table 2). These data suggest that the stability of the dimer was af-
fected, although not disrupted, by changing the DD–EE loop con-
tacts at interface I. Disrupting the DD–EE loop interface was not
sufﬁcient to abolish dimer formation: this could be due to the sta-
bilizing effect of the a-tail wrapping of the TIR domains. Changing
residues from interface II had no effect on the protein stability or
oligomeric state. The AB dimer (interface I) is therefore more likely
to represent the conformation of the protein in solution, a confor-
mation in agreement with the study of the dimeric PdTIR where
this interface was assessed by deuterium exchange experiments
[5].4. Discussion
TIR domain proteins from pathogenic bacteria have recently
emerged as a new class of virulence proteins directly targeting
TLR-dependent immune signalling [11,13,14]. Two translocated
Brucella effector proteins, BtpA and BtpB [19] were identiﬁed as
TIR domain-containing proteins, but their mode(s) of action is still
poorly understood. The only bacterial TIR protein that has been
crystallized so far is PdTIR from non-pathogenic P. denitriﬁcans
[5]. The structure of the Brucella BtpA TIR domain we have solved
shows most resemblance to PdTIR except for the DE loop that is
more similar to those of mammalian MyD88 and TIRAP. The struc-
tures of PdTIR and BtpA dimers are very similar. This dimer archi-
tecture raises important functional questions about TIR-containing
bacterial virulence factors. Indeed, a peptide derived from TcpC DD
loop was found to bind to the MyD88 TIR domain [2]. The organi-
sation of the dimer as seen in the crystal structure of BtpA buries
most of the DD loop residues side chains making it unlikely that
BtpA interacts with MyD88 via the same residues as TcpC
(Fig. 3). Accordingly BtpA was found to bind the MyD88 death do-
main [21]. These elements suggest that TcpC and BtpA, despite
sharing a TIR domain, are likely to have different modes of binding
to MyD88 and thus most likely play different roles during
infection.
Our BtpA structure revealed that a unique a-tail wraps around
two TIR domains hereby delineating a large hydrophobic groove
formed by the dimer. This original organisation is observed for
the ﬁrst time in TIR domain interactions and reinforces the hypoth-
esis that the AB dimer is physiologically relevant. It suggests that
the full length BtpA dimer is not symmetrical and that N-terminal
domains might interact with each other independently to form a
separate functional unit. However, considering that the loop con-
necting the a-tail to the TIR domain appears very ﬂexible, different
organisations of the full-length protein dimer might also be possi-
ble in solution since the N-terminus is believed to form coiled-coils
[29].
In addition to a role in inhibition of TLR signalling, BtpA was
shown to modify microtubule dynamics [22,30]. The structure re-
veals that the surface containing the last residues of the BB loop
is accessible, in particular, G183 (Fig. 3 and Fig. S1). This residue
has been shown to be critical for BtpA interaction with microtu-
bules, as well as inhibition of TLR signalling, and a link between
these processes has been hypothesised [22]. The structure of BtpA
suggests that in the present conformation, a dimer of BtpA presents
two binding sites at opposite sides of the dimer (Fig. 3). Biochem-
ical and structural work to further reﬁne and characterize the
structure of BtpA is on-going to be able to address these questions.
The presented crystal structure will facilitate future studies aiming
at deciphering the molecular details of how BtpA and other
Fig. 3. Two different views of the accessible surface of the BtpA dimer. Residues
from the BB loop are coloured in orange, G183 in red and DD loop in blue.
3416 B. Kaplan-Türköz et al. / FEBS Letters 587 (2013) 3412–3416bacterial TIR proteins modulate the innate immune response
during bacterial infections, but also help in better understanding
the evolutionary basis of TIR proteins, and possible differences
between the yet uncharacterized role of non-pathogenic versus
pathogenic bacterial TIR proteins.
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